Keyphrases
Acquired Drug Resistance
33%
Anti-apoptotic Bcl-2
50%
Anticancer Activity
16%
B-cell Lymphoma 2 (Bcl-2)
16%
Bcl-2 Antagonist
16%
Bcl-2 Family Proteins
100%
Bcl-xL
16%
Binding Potency
16%
Cancer Chemotherapy
16%
Cancer Phenotype
16%
Clinical Potential
16%
Conventional Therapy
16%
Cytotoxicity
16%
Drug Resistance
100%
Ging
16%
Gossypol
16%
Hormone-sensitive Prostate Cancer
100%
Induced Apoptosis
16%
Median Survival
16%
Multidrug-resistant
66%
Overexpressing
33%
PC-3
33%
PC-3 Cell Line
33%
PC-3 Cells
50%
Prostate Cancer Patients
16%
Prostate Tumor Growth
100%
Selective Toxicity
16%
Small Molecule Antagonist
16%
Tumor Growth in Vivo
16%
Pharmacology, Toxicology and Pharmaceutical Science
Antiapoptotic
50%
Cancer Chemotherapy
16%
Castration Resistant Prostate Cancer
100%
Cytotoxicity
16%
Drug Resistance
100%
Gossypol
16%
Prostate Tumor
100%
Protein Bcl 2
100%
Tumor Growth
100%